These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37290663)

  • 1. Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.
    Romagnoli E; Burzotta F; Cerracchio E; Russo G; Aurigemma C; Pedicino D; Locorotondo G; Graziani F; Leone AM; D'Amario D; Lombardo A; Malara S; Fulco L; Bianchini F; Sanna T; Trani C
    Int J Cardiol; 2023 Sep; 387():131098. PubMed ID: 37290663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction.
    Russo G; Burzotta F; D'Amario D; Ribichini F; Piccoli A; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Trani C; Crea F
    Int J Cardiol; 2019 Jan; 274():221-225. PubMed ID: 30057165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of left ventricular function after percutaneous coronary intervention in patients with stable coronary artery disease and preserved ejection fraction: Impact of diabetes mellitus.
    Sikora-Frac M; Zaborska B; Maciejewski P; Budaj A; Bednarz B
    Cardiol J; 2021; 28(6):923-931. PubMed ID: 31257568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry.
    Burzotta F; Russo G; Ribichini F; Piccoli A; D'Amario D; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Crea F; Trani C
    J Interv Cardiol; 2019; 2019():5243913. PubMed ID: 31772533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Russo JJ; Prasad M; Doshi D; Karmpaliotis D; Parikh MA; Ali ZA; Popma JJ; Pershad A; Ohman EM; Douglas PS; O'Neill WW; Leon MB; Moses JW; Kirtane AJ
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):764-770. PubMed ID: 31693292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.
    Becher T; Eder F; Baumann S; Loßnitzer D; Pollmann B; Behnes M; Borggrefe M; Akin I
    Medicine (Baltimore); 2018 Oct; 97(43):e12665. PubMed ID: 30412063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical role of post-angioplasty hyperemic microvascular resistances in chronic ischemic left ventricular dysfunction.
    Gorla R; Verna E; Scotti S; Ghiringhelli S; Zoli L; Provasoli S; Garancini S; De Ponti R; Salerno-Uriarte JA
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):332-340. PubMed ID: 27898505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Grafting in Patients with Multi-Vessel Coronary Disease and Left Ventricular Dysfunction.
    Yee NP; Siu AM; Davis J; Kao J
    Hawaii J Med Public Health; 2016 Sep; 75(9):273-7. PubMed ID: 27688953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry.
    Baumann S; Werner N; Al-Rashid F; Schäfer A; Bauer T; Sotoudeh R; Bojara W; Shamekhi J; Sinning JM; Becher T; Eder F; Akin I
    Coron Artery Dis; 2020 May; 31(3):237-242. PubMed ID: 31658135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hypertension on postreperfusion left ventricular recovery in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.
    Vaicekavičius E; Vasiliauskas D; Navickas R; Milvidaitė I; Unikas R; Venclovienė J; Kubilius R
    Medicina (Kaunas); 2015; 51(1):38-45. PubMed ID: 25744774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose dobutamine echocardiography predicts recovery of left ventricular systolic function following revascularization even in presence of low contractile reserve.
    Kasliwal RR; Paul B; Mustaqueem A; Bansal M; Trehan N
    Indian Heart J; 2006; 58(2):120-5. PubMed ID: 18989055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler echocardiographic myocardial stunning index predicts recovery of left ventricular systolic function after primary percutaneous coronary intervention.
    Sharif D; Matanis W; Sharif-Rasslan A; Rosenschein U
    Echocardiography; 2016 Oct; 33(10):1465-1471. PubMed ID: 27543440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in patients undergoing complex, high-risk percutaneous coronary intervention and haemodynamic support with intra-aortic balloon versus Impella pump: Real-life single-centre preliminary results.
    Januszek R; Pawlik A; Rzeszutko Ł; Bartuś K; Bartuś S
    Kardiol Pol; 2022; 80(12):1224-1231. PubMed ID: 36047958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Vis MM; Koch KT; Paulus WJ; de Mol BA; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):187-94. PubMed ID: 19941329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry.
    Baumann S; Werner N; Ibrahim K; Westenfeld R; Al-Rashid F; Sinning JM; Westermann D; Schäfer A; Karatolios K; Bauer T; Becher T; Akin I
    Clin Res Cardiol; 2018 Aug; 107(8):653-657. PubMed ID: 29520699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation.
    Freixa X; Chan J; Bonan R; Ibrahim R; Lamarche Y; Demers P; Basmadjian A; Ibrahim R; Cartier R; Asgar AW
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):450-8. PubMed ID: 25115215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.